(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 8.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.85%.
Treace Medical Concepts's revenue in 2025 is $213,751,000.On average, 8 Wall Street analysts forecast TMCI's revenue for 2025 to be $14,632,159,444, with the lowest TMCI revenue forecast at $14,035,173,403, and the highest TMCI revenue forecast at $15,093,323,264. On average, 8 Wall Street analysts forecast TMCI's revenue for 2026 to be $16,011,860,516, with the lowest TMCI revenue forecast at $15,229,777,216, and the highest TMCI revenue forecast at $16,598,107,125.
In 2027, TMCI is forecast to generate $17,244,368,204 in revenue, with the lowest revenue forecast at $16,406,060,822 and the highest revenue forecast at $18,092,151,555.